This MEDVi review comes down to two records that flatly disagree. On Trustpilot, MEDVi scores about 4.4/5 across roughly 14,000 reviews — one of the strongest customer records we track. On the BBB, the same company holds an F rating with 662 complaints, 100 of them unanswered. Between those two poles sits a genuinely useful product: compounded semaglutide at $179 the first month, then a flat $299/month, in your choice of weekly injection or daily dissolvable tablet. That mix earns MEDVi 7.6/10 (Good) in our rankings. Here is everything we verified in July 2026.
What Is MEDVi?
MEDVi is a cash-pay telehealth weight-loss platform operated by MEDVi, LLC, headquartered at 131 Continental Drive in Newark, Delaware. The company launched in 2023, and per its own January 2026 press release, more than 100,000 patients have used the platform since.
Its core products are compounded semaglutide and compounded tirzepatide, sold in two forms: the standard weekly injection and a daily oral dissolvable tablet — a pairing few GLP-1 telehealth platforms offer. Neither compounded drug is FDA-approved, and to its credit, MEDVi’s own site says plainly that its compounded products are not FDA-approved or evaluated for safety, efficacy, or quality. Brand-name Wegovy, Zepbound, and Ozempic are also listed when available, at much higher prices.
MEDVi does not employ its own doctors. Prescriptions come from independent licensed clinicians through OpenLoop Health, who review your intake asynchronously. The company serves 49 states per U.S. News, and it accepts no insurance — this is a cash-pay operation, though HSA/FSA payments work.
One housekeeping note: MEDVi (medvi.org) is frequently confused with MEDvidi, an unrelated San Jose mental-health telehealth company. Some negative reviews online are misdirected between the two, so check which company a review is actually about before you weigh it.
MEDVi Pricing in 2026
MEDVi’s own pricing page renders its numbers through JavaScript placeholders, so we verified pricing through the company’s January 7, 2026 press release and third-party provider reviews. Here is the picture.
| Medication | First Month | Refills | Rises With Dose? |
|---|---|---|---|
| Compounded semaglutide injection | $179 | $299/mo flat | No |
| Compounded semaglutide tablets | $249 | Not published (up to $369 per third-party reviews) | Not stated |
| Compounded tirzepatide injection | From $349 | $399–$499 per third-party reports | Reported to vary by dose |
| Brand-name Wegovy / Zepbound | $99 membership + medication cost | Varies | Priced by brand |
| Brand-name Ozempic | — | $1,999/mo (per company press release) | — |
The compounded plans are advertised as all-inclusive: provider review, medication, free expedited shipping, and unlimited telehealth support in one monthly price, with no membership fee. That bundling is real value — Ro and Hers charge up to $149/month in membership before any medication ships. Brand-name plans are the exception: those carry a $99 membership fee on top of medication cost, per MEDVi’s official landing page.
If the daily tablet interests you, note the disclosure gap: MEDVi publishes the $249 first-month tablet price but not the refill price, which third-party reviews put as high as $369. Compare tablet and pill programs across the market in our roundup of oral GLP-1 options before assuming the tablet is the cheaper path.
The $179-to-$299 Jump
MEDVi’s advertising leans hard on the $179 first-month price. Your real ongoing cost is $299/month — a 67% jump after the promo month. The upside is that $299 is genuinely flat: it does not rise as your semaglutide dose escalates, which is where dose-tiered competitors quietly get expensive. The flat-rate promise applies to the semaglutide injection plan; tirzepatide refill prices are not published, and third parties report they climb with dose.
Two more billing flags from our research. One review site reports that MEDVi bills on a 28-day cycle, which works out to roughly 13 charges per year rather than 12 — about an extra month’s cost annually if accurate. And refunds are generally unavailable once medication has been ordered and dispensed for a cycle, so a charge you missed is usually a charge you keep.
How MEDVi Works
The process is asynchronous and fast by industry standards.
- Online evaluation. You complete a short medical questionnaire covering weight history, medications, and conditions. Enrollment and payment do not guarantee a prescription.
- Clinician review within about 24 hours. Independent licensed providers through OpenLoop Health review your intake — no video visit needed in most states, though some states require a virtual face-to-face consultation. A free doctor consultation can be requested.
- Pharmacy fulfillment. If approved, your prescription goes to one of MEDVi’s named compounding partners: Triad Rx (Daphne, AL), RedRock Pharmacy (St. George, UT), or Beaker Pharmacy & Compounding (McKinney, TX). One third-party review also names Belmar Pharma Solutions.
- Delivery. Shipping is free and expedited, with treatment typically starting in about a week.
Naming its pharmacies publicly is a transparency step most competitors skip, and it earns MEDVi real points in our rubric. The caveat: MEDVi does not state whether these are 503A pharmacies or 503B outsourcing facilities, and that distinction matters — 503B facilities follow federal manufacturing standards closer to those of drug manufacturers.
MEDVi Results: What to Realistically Expect
There is no clinical trial of MEDVi itself, so honest expectations come from trials of the FDA-approved versions of these molecules. In the STEP 1 trial, semaglutide 2.4mg produced about 14.9% average weight loss over 68 weeks. In SURMOUNT-1, tirzepatide produced up to ~20.9% average weight loss over 72 weeks at the highest dose.
Apply two discounts to those numbers. First, the trials used FDA-approved medication — compounded copies have never been tested in them. Second, results build slowly by design: the FDA-approved semaglutide schedule titrates from 0.25mg to 2.4mg over roughly 16 weeks, so meaningful loss takes months. Any site promising a specific number of pounds by a specific date is marketing, not medicine — and MEDVi cannot guarantee results any more than its rivals can.
MEDVi Review Themes From Real Customers
The volume of MEDVi’s Trustpilot record is its own argument: roughly 14,000 reviews averaging about 4.4/5 suggests most customers get their medication and are satisfied with the MEDVi weight loss program. Very few GLP-1 telehealth companies have accumulated a record that large.
The complaint record tells the other half. The BBB opened MEDVi’s file in March 2025 and now rates it F, not accredited, with 662 complaints — 100 of which the company failed to answer. Recurring themes across BBB and Trustpilot complaints are specific and consistent: unauthorized auto-renewal charges, often $399, double billing, and difficulty cancelling before the next cycle. Combined with the no-refund-after-dispensing policy, the pattern is clear: MEDVi’s billing machinery keeps running unless you stop it, and stopping it is where customers report friction.
MEDVi vs bmiMD
Our top alternative is bmiMD, which scores higher overall at 8.2/10 and costs substantially less month to month. Here is the head-to-head.
| MEDVi | bmiMD | |
|---|---|---|
| Our score | 7.6/10 (Good) | 8.2/10 (Very Good) |
| Semaglutide | $179 first month, then $299/mo | $99/mo (12-month plan) to $129/mo monthly |
| Tirzepatide | From $349; refills $399–$499 per third parties | $139–$159/mo by plan length |
| Membership fee | None on compounded plans | None |
| Price rises with dose | No (semaglutide injection) | No |
| Daily tablet option | Yes, from $249 first month | No |
| Trustpilot | ~4.4/5 (~14,000 reviews) | ~4/5 (~800 reviews) |
| BBB | F, 662 complaints, 100 unanswered | C+, 38 complaints |
On price, it is not close: bmiMD’s refill cost runs $170 to $200 per month below MEDVi’s $299, and its tirzepatide undercuts MEDVi’s reported refill range by roughly $250 or more. bmiMD’s catches are its own — the $99 rate requires a $1,188 upfront annual commitment, all sales are final, and a $50 cancellation fee applies in a narrow window — but its BBB record (C+ with 38 complaints) is far cleaner than MEDVi’s F with 662. Our full bmiMD review walks through the fine print.
MEDVi’s honest counterargument is flexibility and track record: it offers daily tablets and brand-name medication, which bmiMD does not, and its 14,000-review Trustpilot base dwarfs bmiMD’s 800. If neither fully fits, our ranking of the best weight loss injections compares all ten providers we track on the same rubric.
Who Should Use MEDVi — and Who Shouldn’t
MEDVi fits you if you want the option of a daily dissolvable tablet instead of a weekly needle, or you may want to switch between formats without changing providers. It also fits if you value knowing exactly which pharmacies compound your medication — Triad Rx, RedRock, and Beaker are named publicly — and if a flat $299 refill with no dose-based increases beats the teaser-price roulette elsewhere. The 24-hour review turnaround and HSA/FSA acceptance are practical bonuses.
Skip MEDVi if the lowest price is your priority — bmiMD starts at $99/month and several rivals undercut $299 refills. Skip it if you have ever been burned by subscription billing: the documented pattern of auto-renewal complaints and the no-refund policy make MEDVi a poor match for anyone who will not calendar their refill dates. If you want a provider that puts its money behind results instead, ReadyRx offers a full refund if you lose less than 5% of body weight after 28 weeks as prescribed — see our ReadyRx review. And if you are comparing MEDVi’s price structure against lookalikes, OMZO runs a near-identical $199-then-$299 model but with a far thinner track record, as our OMZO review details.
Standard medical exclusions apply here as everywhere: a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome, a history of pancreatitis, pregnancy or planned pregnancy, or an active eating disorder should disqualify you at intake. A provider that screens you out for these is doing its job.
Is MEDVi Legit? Our Verdict
MEDVi is a legitimate company, not a scam. It operates under a real legal entity in Delaware, claims over 100,000 patients through a verifiable press release, names its compounding pharmacies publicly, and routes prescriptions through licensed clinicians via OpenLoop Health. Its Trustpilot record — 4.4/5 across roughly 14,000 reviews — is among the strongest in this industry.
But a fair MEDVi review has to hold both records at once. The BBB rates this company an F, with 662 complaints and 100 ignored. Customers report $399 auto-renewal charges they did not expect, double billing, and cancellation friction, against a policy of no refunds once medication is dispensed. The $179 headline price lasts exactly one month before a 67% jump. Tablet and tirzepatide refill prices are not published at all. And the core products are compounded drugs that are not FDA-approved — a trade-off every compounded buyer should make with open eyes.
MEDVi Review Score: 7.6/10 (Good)
The score nets out this way: strong marks for product flexibility, named pharmacies, flat semaglutide refill pricing, and a large, positive customer base — dragged down hard by the worst unanswered-complaint record among our Good-rated providers and a billing pattern that demands vigilance. If you enroll, set a reminder several days before every refill date, screenshot the pricing at checkout, and treat cancellation as something to do early rather than at the deadline. If that maintenance sounds exhausting, bmiMD and the rest of our rankings are the calmer starting point.